No deaths, 38 new cases of contamination and 56 recoveries were confirmed in the Kingdom on December 17 and 18, 2022. The still active cases stand at 855, while more than 6.8 million people have received a third dose. . Monitoring the pandemic, in figures.
New cases of contamination, remissions, number of screenings carried out, vaccinations, etc. To learn more regarding the evolution of the coronavirus in Morocco, click on this link: https://covid.le360.ma.
© : DR
In the Maghreb, Algeria does not communicate the number of screening tests, which suggests that the number of contaminations is much higher than the official figures. The last assessment stopped does not report four (4) cases of contamination, while no death was deplored. The country totals 271,168 cases of contamination, including 6,881 deaths and 182,612 recoveries.
In Tunisia, 11 new cases of contamination have been recorded, according to the latest available report which does not highlight any deaths. The country has totaled 1,147,282 cases of contamination, including 29,272 deaths and 1,134,050 recoveries since March 2020.
In Mauritania, no case has been recorded, according to the latest report available. The country has recorded 63,425 cases of Covid-19 contamination, including 997 deaths.
Three years ago, the first case of Covid-19 was identified in China, the starting point of a pandemic with unprecedented consequences. How to prevent history from repeating itself? The question mobilizes researchers and States but funding is insufficient and the answers uncertain.
“We are not doing enough to be ready for the next pandemic,” said AFP William Rodriguez, head of Find, a foundation under the aegis of the UN which seeks to improve access to tests. screening around the world.
Among the crucial tools to avoid the emergence of a new pandemic like that of Covid are tests, which help to curb the spread of a disease.
Other devices: the identification of viruses or bacteria that might cause the next pandemic, the discovery of vaccines or emergency treatments, the production and distribution of these products, etc.
The goal? Avoiding a new pandemic following three years of Covid. The first case of this disease was diagnosed in China in December 2019. Less than three months later, the World Health Organization (WHO) formalized the pandemic that shook the world.
Last week, it was within the framework of the WHO that international negotiations began on the fight once morest future pandemics. The World Bank has launched a fund dedicated to the subject and fed by the G20 countries (currently up to 1.6 billion dollars).
“A few mutations”
The initiatives are also private. In Australia, businessman Geoffrey Cumming has spent $170 million to fund a research center run by infectious disease specialist Sharon Lewin.
His team will look into technologies that might serve as the basis for rapidly adaptable treatments once morest new pathogens. Model to follow: messenger RNA vaccines once morest Covid. The center will be “operational” within six months, Professor Lewin told AFP.
The objective here is to know how to respond urgently to an unknown pathogen. But anticipation also involves identifying known risks.
The WHO is thus working on updating a list of risk microbes. To be watched in particular: other coronaviruses as well as the flu virus, of course, but also Ebola and Zika.
“For each of these viruses, only a few mutations” might increase their spread, warns epidemiologist Jennifer Nuzzo, of the American University Brown.
Other pathogens are under surveillance, such as arenaviruses, paramysoviruses -measles and mumps family- or the Marburg virus.
“Many Crises”
Will these research efforts be sufficient? Many experts and activists fear above all a lack of political will. Which translates into the issue of funding. Thus, the CEPI organization (co-founded by several states and the Bill and Melinda Gates foundation to deal with epidemics) is seeking 800 million dollars to complete a five-year plan.
Decision-makers should not forget the pandemic issue even if they are “focused on the many current crises”, in a difficult geopolitical and economically context, said Richard Hatchett, head of CEPI, to AFP.
And how can we ensure that all countries, including the poorest, have access to a vaccine or a treatment? “For me, the tragedy of Covid will have been the uneven distribution of vaccines, even once available,” says the epidemiologist.
Experts interviewed by AFP agree. It will be impossible to respond well to the next pandemic if large regions such as Africa, South America, South Asia or the Middle East do not have access to treatments, in particular by producing them themselves. same.
For many activists, it would already be necessary to plan to lift the patents of possible treatments of major importance. But the idea seems unrealistic in the face of opposition from the pharmaceutical sector and a large part of the developed countries.
And there is little development to expect: the tone adopted by these countries within the framework of the current discussions at the WHO is “extremely worrying”, estimates Mohga Kamal-Yanni, representative of the NGO People’s Vaccine Alliance.
The pandemic has officially killed at least 6,671,655 people worldwide since the end of December 2019, according to a report. The United States is the country with the most deaths (1,112,965), ahead of Brazil (691,830), India (530,672) and Russia (393,000).
The World Health Organization (WHO) estimates, taking into account the excess mortality directly and indirectly linked to Covid-19, that the toll of the pandemic might be two to three times higher than that officially established.
